| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.093 | 0.03 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |